Regulation of Nucleotide Excision Repair by Proteolysis
Regulation of Nucleotide Excision Repair by Proteolysis
批准号:
7622905
负责人:
Pengbo Zhou
金额:
$32.86万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-01 至 2009-05-31
关键词:
ABL1 geneAddressAffectAnimal ModelBindingBinding ProteinsBiochemicalBiochemical GeneticsBiochemical ReactionBiologicalBiological AssayCDKN1A geneCell CycleCell Cycle ArrestCell Cycle RegulationCellsChemicalsComplexConditionDDB Chlorinated HydrocarbonsDNA DamageDNA RepairDNA-Binding ProteinsDevelopmentDiseaseEnsureEventExcision RepairFundingGenomic InstabilityGenomicsGoalsHandHealthHistonesHourHumanKineticsKnockout MiceKnowledgeMalignant NeoplasmsMediatingModificationMolecularMolecular GeneticsMusMutagensMutateNucleotide Excision RepairPathway interactionsPersonal SatisfactionPhosphotransferasesPhysiologicalPlayPositioning AttributePreventionPrevention strategyProteolysisReagentRegulationRegulatory PathwayResistanceRoleSiteSkinSkin CancerSkin CarcinogenesisSkin NeoplasmsStructureTestingTimeTumor SuppressionTumorigenicityUbiquitinUbiquitinationUltraviolet RaysUp-RegulationXeroderma Pigmentosumabstractingaplidinebasec-abl Proto-Oncogenescarcinogenesiscitrate carriercullin 4Adesignimprovedin vivoinsightirradiationkeratinocytekinase inhibitormulticatalytic endopeptidase complexmutantnovelnovel strategiesoncoprotein p21photolesionpreventrepairedsensorstructural biologytumortumorigenesisubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Nucleotide excision repair (NER) is the major DNA repair machinery that removes DNA damage induced by
ultraviolet light (UV) and chemical mutagens to prevent genomic instability and tumorigenesis. While the
enzymatic reactions for excision and repair of DNA photolesions are well studied, regulatory pathways
governing the temporal and spatial control of DNA damage recognition remains poorly understood, and the
physiological functions of such regulation on tumor suppression have not been explored due to the
unavailability of animal models. The cullin 4A (CUL-4A) ubiquitin ligase has recently emerged as a key
regulator of two DNA damage sensors: the damaged DNA binding proteins (DDBs, heterodimers of DDB1 and
DDB2) and xeroderma pigmentosum complementation group C (XPC) protein. Interestingly, recent studies
revealed a second function of DDBs as integral components of the CUL-4A ubiquitin ligase complex. During
the previous funding period, our biochemical and structural biology studies provided mechanistic insight into
the assembly of the CUL-4A-DDB complex, and a novel kinase-independent function of c-Abl in activating
CUL-4A-dependent ubiquitination of DDBs both under normal conditions and upon UV irradiation. Importantly,
we generated conditional CUL-4A knockout mice and showed that skin-specific CUL-4A knockout mice were
resistant to UV-induced skin carcinogenesis, suggesting an intriguing possibility of pharmacological inhibition
of CUL-4A as a prevention strategy for UV-induced skin cancer. We also collaborated with Dr. Stephan Goff to
determine the physiological functions of DDB1 in NER and in controlling cell cycle and genomic integrity in the
conditional DDB1 knockout mice. Interestingly, our in vivo studies revealed dramatic upregulation of the cyclindependent
kinase inhibitor p21/CIP1/WAF1 in CUL-4A-/- and DDB1-/- mice, as well as in MEF cells and
keratinocytes derived from these mice. Our long-term goal is to understand how the ubiquitin pathway
regulates DNA repair and affects tumor development. We hypothesize that the CUL-4A ubiquitin ligase
activity is precisely controlled both to ensure proper execution of NER and to halt cell cycle events to allow
time for efficient repair. We are uniquely positioned to test this hypothesis since we have generated specific
ubiquitination-resistant DDB2 mutants, identified a novel modulator (BRAP2) in the temporal control of CUL-4A
activity following UV irradiation, and have CUL-4A, DDB1 and p21 (or CIP1 or WAF1) knockout mice in hand.
We propose to employ a combination of biochemical, genetic and cell biological approaches to address the
following three specific aims: (1) establish the mechanism by which CUL-4A ubiquitination of DDB2 regulates
damage recognition and repair; (2) To determine the temporal control of CUL-4A ubiquitin ligase activity by
BRAP2 during NER; (3) To determine the mechanistic basis and functional significance of p21 accumulation in
protecting CUL-4A-deficient mice against UV-induced carcinogenesis. Successful completion of these aims will
significantly contribute to our understanding of the molecular and genetic basis of the ubiquitin-proteasome
pathway in DNA repair and tumorigenesis. Knowledge gained from these efforts could be exploited to devise
novel strategies for the prevention and/or treatment of UV- and chemical mutagen-induced skin cancer or skinrelated
disorders, and thus improve the health and well-being of humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small Molecule CUL4 Inhibitors as Dual Precision Oncology and Immuno-Oncology Drugs
-
批准号:10673021
-
项目类别:
-
资助金额:$24.61万
-
财政年份:2022
-
负责人:Pengbo Zhou
-
依托单位:
G3BP1 Suppresses SPOP Ubiquitin Ligase to Promote Prostate Tumorigenesis
-
批准号:10328476
-
项目类别:
-
资助金额:$48.25万
-
财政年份:2018
-
负责人:Pengbo Zhou
-
依托单位:
Harnessing the CRL4 ubiquitin ligase for antagonizing colorectal carcinogenesis
-
批准号:9261925
-
项目类别:
-
资助金额:$51.39万
-
财政年份:2017
-
负责人:Pengbo Zhou
-
依托单位:
Development of high throughput assays to identify small molecule inhibitors of th
-
批准号:8103587
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2011
-
负责人:Pengbo Zhou
-
依托单位:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
-
批准号:7016787
-
项目类别:
-
资助金额:$31.62万
-
财政年份:2006
-
负责人:Pengbo Zhou
-
依托单位:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
-
批准号:7336353
-
项目类别:
-
资助金额:$29.06万
-
财政年份:2006
-
负责人:Pengbo Zhou
-
依托单位:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
-
批准号:7173460
-
项目类别:
-
资助金额:$29.06万
-
财政年份:2006
-
负责人:Pengbo Zhou
-
依托单位:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
-
批准号:7754060
-
项目类别:
-
资助金额:$29.06万
-
财政年份:2006
-
负责人:Pengbo Zhou
-
依托单位:
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
-
批准号:7547053
-
项目类别:
-
资助金额:$29.06万
-
财政年份:2006
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:8245783
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:7073492
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:7228594
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:7784492
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:8064808
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:7595614
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:6765905
-
项目类别:
-
资助金额:$33.94万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:6923955
-
项目类别:
-
资助金额:$33.94万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:6680414
-
项目类别:
-
资助金额:$33.94万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Regulation of Nucleotide Excision Repair by Proteolysis
-
批准号:8449697
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2003
-
负责人:Pengbo Zhou
-
依托单位:
Protein Knockout Technology/Molecular Analysis of Cancer
-
批准号:6779221
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2001
-
负责人:Pengbo Zhou
-
依托单位:
海外基金